Brian S. Crenshaw

1.9k total citations
9 papers, 1.3k citations indexed

About

Brian S. Crenshaw is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brian S. Crenshaw has authored 9 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Cardiology and Cardiovascular Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brian S. Crenshaw's work include Acute Myocardial Infarction Research (6 papers), Cardiac Valve Diseases and Treatments (3 papers) and Coronary Interventions and Diagnostics (3 papers). Brian S. Crenshaw is often cited by papers focused on Acute Myocardial Infarction Research (6 papers), Cardiac Valve Diseases and Treatments (3 papers) and Coronary Interventions and Diagnostics (3 papers). Brian S. Crenshaw collaborates with scholars based in United States, Chile and United Kingdom. Brian S. Crenshaw's co-authors include Eric J. Topol, Christopher B. Granger, Neal S. Kleiman, Robert M. Califf, Robert M. Califf, Yochai Birnbaum, Alec Vahanian, Karen S. Pieper, Douglas C. Morris and Samuel R. Ward and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Brian S. Crenshaw

9 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian S. Crenshaw United States 8 1.1k 836 336 322 120 9 1.3k
Francesco Chiarella Italy 20 1.4k 1.2× 409 0.5× 428 1.3× 153 0.5× 189 1.6× 61 1.6k
Claudio De Vita Italy 15 899 0.8× 371 0.4× 408 1.2× 110 0.3× 62 0.5× 29 1.1k
Hans–Henrik Tilsted Denmark 17 1.2k 1.1× 979 1.2× 677 2.0× 60 0.2× 30 0.3× 48 1.5k
Iwan C. van der Horst Netherlands 8 1.2k 1.1× 873 1.0× 584 1.7× 63 0.2× 80 0.7× 10 1.4k
Bram Zuckerman United States 9 610 0.5× 560 0.7× 295 0.9× 39 0.1× 29 0.2× 24 846
Robert M. Califf United States 13 577 0.5× 453 0.5× 318 0.9× 34 0.1× 30 0.3× 16 802
Fredrik Scherstén Sweden 15 623 0.5× 431 0.5× 148 0.4× 49 0.2× 26 0.2× 25 774
Matthew Lumley United Kingdom 14 541 0.5× 364 0.4× 318 0.9× 187 0.6× 53 0.4× 31 860
Luiz Bóro Puig Brazil 12 574 0.5× 524 0.6× 165 0.5× 65 0.2× 101 0.8× 41 742
Denise Jones United States 12 817 0.7× 642 0.8× 459 1.4× 151 0.5× 31 0.3× 21 981

Countries citing papers authored by Brian S. Crenshaw

Since Specialization
Citations

This map shows the geographic impact of Brian S. Crenshaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian S. Crenshaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian S. Crenshaw more than expected).

Fields of papers citing papers by Brian S. Crenshaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian S. Crenshaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian S. Crenshaw. The network helps show where Brian S. Crenshaw may publish in the future.

Co-authorship network of co-authors of Brian S. Crenshaw

This figure shows the co-authorship network connecting the top 25 collaborators of Brian S. Crenshaw. A scholar is included among the top collaborators of Brian S. Crenshaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian S. Crenshaw. Brian S. Crenshaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Mahaffey, Kenneth W., Robert A. Harrington, K. Martijn Akkerhuis, et al.. (2001). Systematic adjudication of myocardial infarction end-points in an international clinical trial. Trials. 2(4). 180–186. 51 indexed citations
2.
Mahaffey, Kenneth W., Robert A. Harrington, K. Martijn Akkerhuis, et al.. (2001). Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study. Trials. 2(4). 187–194. 54 indexed citations
3.
Birnbaum, Yochai, Galen S. Wagner, Kathy Gates, et al.. (2000). Clinical and electrocardiographic variables associated with increased risk of ventricular septal defect in acute anterior myocardial infarction. The American Journal of Cardiology. 86(8). 830–834. 10 indexed citations
4.
Crenshaw, Brian S., Christopher B. Granger, Yochai Birnbaum, et al.. (2000). Risk Factors, Angiographic Patterns, and Outcomes in Patients With Ventricular Septal Defect Complicating Acute Myocardial Infarction. Circulation. 101(1). 27–32. 475 indexed citations
5.
Califf, Robert M., Alaa E. Abdelmeguid, Richard E. Kuntz, et al.. (1998). Myonecrosis After Revascularization Procedures. Journal of the American College of Cardiology. 31(2). 241–251. 413 indexed citations
6.
Ardissino, Diego, et al.. (1998). Coagulation markers and outcomes in acute coronary syndromes. American Heart Journal. 136(4). s7–s18. 9 indexed citations
8.
Crenshaw, Brian S., Karen S. Pieper, Neal S. Kleiman, et al.. (1996). Risk factors and outcomes in patients with ventricular septal defects (VSD) complicating acute MI. Journal of the American College of Cardiology. 27(2). 67–68. 1 indexed citations
9.
Crenshaw, Brian S., Robert A. Harrington, & James E. Tcheng. (1995). Section Review: Cardiovascular & Renal: Novel antiplatelet agents: The glycoprotein IIb/IIIa inhibitors. Expert Opinion on Investigational Drugs. 4(11). 1033–1044. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026